The role of inflammation in the metabolic syndrome

Aims and Objectives: The aim of this study is to determine the plasma levels of interleukin-6 (IL-6), tumor necrosis factor alpha (TNFα) and C-reactive protein (CRP) in adult Nigerians with the metabolic syndrome and to determine the relationship between components of the metabolic syndrome and CRP...

Full description

Bibliographic Details
Main Authors: Ifeoma C Udenze, Casmir E Amadi, Nicholas A Awolola, Christian C Makwe, Obiefuna I Ajie
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Journal of Clinical Sciences
Subjects:
Online Access:http://www.jcsjournal.org/article.asp?issn=2468-6859;year=2016;volume=13;issue=1;spage=17;epage=22;aulast=Udenze
_version_ 1819029800534147072
author Ifeoma C Udenze
Casmir E Amadi
Nicholas A Awolola
Christian C Makwe
Obiefuna I Ajie
author_facet Ifeoma C Udenze
Casmir E Amadi
Nicholas A Awolola
Christian C Makwe
Obiefuna I Ajie
author_sort Ifeoma C Udenze
collection DOAJ
description Aims and Objectives: The aim of this study is to determine the plasma levels of interleukin-6 (IL-6), tumor necrosis factor alpha (TNFα) and C-reactive protein (CRP) in adult Nigerians with the metabolic syndrome and to determine the relationship between components of the metabolic syndrome and CRP in adult Nigerians. Materials and Methods: This was a cross-sectional analytical study of 50 adult men and women with metabolic syndrome and 50 age- and sex-matched men and women without metabolic syndrome. Metabolic syndrome was defined based on the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) criteria. Written informed consent was obtained from the participants. Blood pressure and anthropometric measurements were taken and venous blood was collected after an overnight fast. The Ethics Committee of the Lagos University Teaching Hospital, Lagos, Lagos State, Nigeria approved the study protocol. Comparisons of the continuous variables and the categorical variables were done using the Student's t-test and Chi-square test, respectively. Regression analysis was used to determine the associations between the variables. Statistical significance was set at P < 0.05. Results: The study subjects differed in some clinical and laboratory parameters such as diastolic blood pressure (P = 0.048), waist circumference (P = 0.002), body mass index (BMI) (P = 0.012), waist/hip ratio (P = 0.023), high-density lipoprotein (HDL) (P = 0.012), and insulin resistance (P = 0.042). There was a statistically significant increase in the inflammatory marker, CRP (P = 0.019), cytokines, IL-6 (P = 0.040), and TNFα (P = 0.031) between the subjects with and without metabolic syndrome. There was also a positive significant association between CRP, waist circumference, and insulin resistance and a negative significant association between CRP and HDL in metabolic syndrome (P < 0.05). Conclusion: This study reports increased plasma levels of the inflammatory cytokines, IL-6, TNFα and in the inflammatory marker and CRP in metabolic syndrome. Understanding the role of inflammation in the metabolic syndrome may provide novel strategies for the management of metabolic syndrome and related disorders.
first_indexed 2024-12-21T06:20:01Z
format Article
id doaj.art-4708a550f9e043b5b47c6e4f3acfda3c
institution Directory Open Access Journal
issn 2468-6859
2408-7408
language English
last_indexed 2024-12-21T06:20:01Z
publishDate 2016-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Clinical Sciences
spelling doaj.art-4708a550f9e043b5b47c6e4f3acfda3c2022-12-21T19:13:17ZengWolters Kluwer Medknow PublicationsJournal of Clinical Sciences2468-68592408-74082016-01-01131172210.4103/1595-9587.175484The role of inflammation in the metabolic syndromeIfeoma C UdenzeCasmir E AmadiNicholas A AwololaChristian C MakweObiefuna I AjieAims and Objectives: The aim of this study is to determine the plasma levels of interleukin-6 (IL-6), tumor necrosis factor alpha (TNFα) and C-reactive protein (CRP) in adult Nigerians with the metabolic syndrome and to determine the relationship between components of the metabolic syndrome and CRP in adult Nigerians. Materials and Methods: This was a cross-sectional analytical study of 50 adult men and women with metabolic syndrome and 50 age- and sex-matched men and women without metabolic syndrome. Metabolic syndrome was defined based on the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) criteria. Written informed consent was obtained from the participants. Blood pressure and anthropometric measurements were taken and venous blood was collected after an overnight fast. The Ethics Committee of the Lagos University Teaching Hospital, Lagos, Lagos State, Nigeria approved the study protocol. Comparisons of the continuous variables and the categorical variables were done using the Student's t-test and Chi-square test, respectively. Regression analysis was used to determine the associations between the variables. Statistical significance was set at P < 0.05. Results: The study subjects differed in some clinical and laboratory parameters such as diastolic blood pressure (P = 0.048), waist circumference (P = 0.002), body mass index (BMI) (P = 0.012), waist/hip ratio (P = 0.023), high-density lipoprotein (HDL) (P = 0.012), and insulin resistance (P = 0.042). There was a statistically significant increase in the inflammatory marker, CRP (P = 0.019), cytokines, IL-6 (P = 0.040), and TNFα (P = 0.031) between the subjects with and without metabolic syndrome. There was also a positive significant association between CRP, waist circumference, and insulin resistance and a negative significant association between CRP and HDL in metabolic syndrome (P < 0.05). Conclusion: This study reports increased plasma levels of the inflammatory cytokines, IL-6, TNFα and in the inflammatory marker and CRP in metabolic syndrome. Understanding the role of inflammation in the metabolic syndrome may provide novel strategies for the management of metabolic syndrome and related disorders.http://www.jcsjournal.org/article.asp?issn=2468-6859;year=2016;volume=13;issue=1;spage=17;epage=22;aulast=UdenzeInflammationinsulin resistancemetabolic syndromeobesity
spellingShingle Ifeoma C Udenze
Casmir E Amadi
Nicholas A Awolola
Christian C Makwe
Obiefuna I Ajie
The role of inflammation in the metabolic syndrome
Journal of Clinical Sciences
Inflammation
insulin resistance
metabolic syndrome
obesity
title The role of inflammation in the metabolic syndrome
title_full The role of inflammation in the metabolic syndrome
title_fullStr The role of inflammation in the metabolic syndrome
title_full_unstemmed The role of inflammation in the metabolic syndrome
title_short The role of inflammation in the metabolic syndrome
title_sort role of inflammation in the metabolic syndrome
topic Inflammation
insulin resistance
metabolic syndrome
obesity
url http://www.jcsjournal.org/article.asp?issn=2468-6859;year=2016;volume=13;issue=1;spage=17;epage=22;aulast=Udenze
work_keys_str_mv AT ifeomacudenze theroleofinflammationinthemetabolicsyndrome
AT casmireamadi theroleofinflammationinthemetabolicsyndrome
AT nicholasaawolola theroleofinflammationinthemetabolicsyndrome
AT christiancmakwe theroleofinflammationinthemetabolicsyndrome
AT obiefunaiajie theroleofinflammationinthemetabolicsyndrome
AT ifeomacudenze roleofinflammationinthemetabolicsyndrome
AT casmireamadi roleofinflammationinthemetabolicsyndrome
AT nicholasaawolola roleofinflammationinthemetabolicsyndrome
AT christiancmakwe roleofinflammationinthemetabolicsyndrome
AT obiefunaiajie roleofinflammationinthemetabolicsyndrome